drugset / Trial / NCT00576511

Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation

NCT00576511

Phase 2 Completed 53 enrolled Movetis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether prucalopride is safe and effective in patients with severe chronic constipation.

Timeline

Start
1994-12
Primary completion
1996-02
Completion
1996-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prucalopride Small molecule 4 mg

Indications